文献速递烧伤创面修复

骨髓间充质干细胞联合辛伐他汀激活Akt/mTOR通路加速大鼠烧伤创面愈合

Bone Marrow-Derived Mesenchymal Stem Cells Combined With Simvastatin Accelerates Burn Wound Healing by Activation of the Akt/mTOR Pathway.
PubMed 文献 · J Burn Care Res · 2020-01-01

本研究在大鼠二度烧伤模型中探讨骨髓间充质干细胞(BMSCs)联合辛伐他汀(SMV)对创面愈合、血管生成及Akt/mTOR通路的影响。40只成年雄性Wistar大鼠随机分为对照、SMV、BMSCs和联合治疗组,治疗后14天取创面行组织学和分子分析。联合治疗在创面闭合面积、表皮再生、胶原沉积和再上皮化率方面优于单一治疗,且Akt/mTOR表达及CD31、VEGF基因表达升高更显著。

要点

  • BMSCs联合SMV较单一治疗更显著促进大鼠二度烧伤创面闭合与再上皮化。
  • 联合治疗更显著上调Akt和mTOR的mRNA及蛋白表达(P<.05)。
  • 联合治疗组CD31和VEGF基因表达最高(P<.01)。

核心结论

  • BMSCs移植联合局部辛伐他汀对大鼠烧伤创面愈合有较大潜力,其获益至少部分通过激活Akt/mTOR信号通路实现。

研究设计与样本

  • 研究为动物实验,40只成年雄性Wistar大鼠建立二度烧伤创面后随机分为对照、SMV、BMSCs和BMSCs+SMV四组。
  • 治疗开始后14天处死动物,取创面进行组织学和分子分析。

主要发现

  • 联合治疗在创面闭合面积、表皮再生水平、胶原沉积强度和再上皮化率方面均优于单一治疗。
  • BMSCs+SMV组Akt和mTOR基因在mRNA和蛋白水平的表达升高更明显(qRT-PCR和Western blot评估P<.05)。
  • 联合治疗组CD31和VEGF基因表达水平最高(所有比较P<.01)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Burn wound healing is one of the most important problems in the field of medical science. Promising results have recently been reported by researchers who used bone marrow mesenchymal stem cells (BMSCs) to treat burn wounds. In this study, we investigated the effects of BMSC therapy in combination with simvastatin (SMV) on angiogenesis as well as on the activity of the Akt/mTOR signaling pathway during burn wound healing in rats. After creating second-degree burn wounds, 40 adult male Wistar rats were randomly divided into four treatment groups: the control, SMV, BMSCs, and the combination therapy group (BMSCs+SMV). Animals were killed 14 days after treatment initiation, and the wounds were removed for histological and molecular analyses. All in all, combination therapy produced better outcomes than individual therapy in terms of the wound closure area, epidermal regeneration level, collagen deposition intensity, and reepithelialization rate. In addition, the elevations of expression levels of Akt and mTOR genes, at both mRNA and protein levels, were more pronounced in the BMSCs+SMV group (P < .05, at least, for both qRT-PCR and western blot assessments). qRT-PCR findings also demonstrated that the wounds treated with the combination of BMSCs and SMV had the highest expression levels of CD31 and VEGF genes (P < .01 for all comparisons). These data suggest that the combined administration of BMSCs transplantation and topical SMV has a great potential in burn wound healing. According to the findings, the beneficial effects of the combination therapy are caused, at least in part, through stimulating Akt/mTOR signaling pathway.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Ramhormozi P, Mohajer Ansari J, Simorgh S, et al. Bone Marrow-Derived Mesenchymal Stem Cells Combined With Simvastatin Accelerates Burn Wound Healing by Activation of the Akt/mTOR Pathway. J Burn Care Res. 2020. PMID: 32157277. doi:10.1093/jbcr/iraa005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。